| ［1］ |
刘宇甄, 曾荣, 徐浩翔, 等. 痤疮发病相关的重要皮肤微生物群研究进展［J］. 中华皮肤科杂志, 2019,52（5）:346⁃349. doi: 10.3760/cma.j.issn.0412⁃4030.2019.05.015.
|
| ［2］ |
Karoglan A, Paetzold B, Pereira de Lima J, et al. Safety and efficacy of topically applied selected cutibacterium acnes strains over five weeks in patients with acne vulgaris: an open⁃label, pilot study［J］. Acta Derm Venereol, 2019,99（13）:1253⁃1257. doi: 10.2340/00015555⁃3323.
|
| ［3］ |
Higaki S, Kitagawa T, Kagoura M, et al. Correlation between propionibacterium acnes biotypes, lipase activity and rash degree in acne patients［J］. J Dermatol, 2000,27（8）:519⁃522. doi: 10.1111/j.1346⁃8138.2000.tb02219.x.
|
| ［4］ |
Lee YB, Byun EJ, Kim HS. Potential role of the microbiome in acne: a comprehensive review［J］. J Clin Med, 2019,8（7）doi: 10.3390/jcm8070987.
|
| ［5］ |
孙超楠, 沈柱. 肠道菌群紊乱与慢性炎症性皮肤病的研究进展［J］. 实用皮肤病学杂志, 2018,11（4）:225⁃227. doi: 10. 11786/sypfbxzz.1674⁃1293.20180410.
|
| ［6］ |
Ellis SR, Nguyen M, Vaughn AR, et al. The skin and gut microbiome and its role in common dermatologic conditions［J］. Microorganisms, 2019,7（11）:550. doi: 10.3390/microorganisms 7110550.
|
| ［7］ |
Xu H, Li H. Acne, the skin microbiome, and antibiotic treatment［J］. Am J ClinDermatol, 2019,20（3）:335⁃344. doi: 10.1007/s40257⁃018⁃00417⁃3.
|
| ［8］ |
Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic［J］. Nat Rev Gastroenterol Hepatol, 2014,11（8）:506⁃514. doi: 10.1038/nrgastro.2014.66.
|
| ［9］ |
Goodarzi A, Mozafarpoor S, Bodaghabadi M, et al. The potential of probiotics for treating acne vulgaris: a review of literature on acne and microbiota［J］. Dermatol Ther, 2020,33（3）:e13279. doi: 10.1111/dth.13279.
|
| ［10］ |
Lolou V, Panayiotidis MI. Functional role of probiotics and prebiotics on skin health and disease［J］. Fermentation, 2019,5（2）:41. doi:10.3390/fermentation5020041.
|
| ［11］ |
王萃, 张柳萦, 黄卫新. 肠道菌群与痤疮发生的相关性分析:110例肠道菌群样本的回顾性研究［J］. 中国美容医学, 2018,27（9）:9⁃12.
|
| ［12］ |
Knackstedt R, Knackstedt T, Gatherwright J. The role of topical probiotics in skin conditions: a systematic review of animal and human studies and implications for future therapies［J］. ExpDermatol, 2020,29（1）:15⁃21. doi: 10.1111/exd.14032.
|
| ［13］ |
Burcelin R, Luche E, Serino M, et al. The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?［J］. Front Biosci （Landmark Ed）, 2009,14:5107⁃5117. doi: 10.2741/3589.
|
| ［14］ |
Fabbrocini G, Bertona M, Picazo Ó, et al. Supplementation with Lactobacillus rhamnosus SP1 normalises skin expression of genes implicated in insulin signalling and improves adult acne［J］. Benef Microbes, 2016,7（5）:625⁃630. doi: 10.3920/BM2016. 0089.
|
| ［15］ |
汤红燕, 肖斌, 杨桂兰. 胰岛素样生长因子1受体信号通路在相关皮肤病发病机制中的作用［J］. 中华皮肤科杂志, 2019,52（12）:934⁃936. doi: 10.35541/cjd.20180712.
|
| ［16］ |
Jung GW, Tse JE, Guiha I, et al. Prospective, randomized, open⁃label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne［J］. J Cutan Med Surg, 2013,17（2）:114⁃122. doi: 10.2310/7750.2012. 12026.
|
| ［17］ |
Bowe WP, Filip JC, DiRienzo JM, et al. Inhibition of propionibacterium acnes by bacteriocin⁃like inhibitory substances （BLIS） produced by Streptococcus salivarius［J］. J Drugs Dermatol, 2006,5（9）:868⁃870.
|
| ［18］ |
Wang Y, Kuo S, Shu M, et al. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris［J］. Appl Microbiol Biotechnol, 2014,98（1）:411⁃424. doi: 10.1007/s00253⁃013⁃5394⁃8.
|
| ［19］ |
Deidda F, Amoruso A, Nicola S, et al. New approach in acne therapy: a specific bacteriocin activity and a targeted anti IL⁃8 property in just 1 probiotic strain, the L. salivarius LS03［J］. J Clin Gastroenterol, 2018,52 suppl 1:S78⁃S81. doi: 10.1097/MCG. 0000000000001053.
|
